4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-054051
Chairman and CEO bought 45,000 shares at an average $0.19 ($8,700)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-10-17 | Purchase | +15,000 | $0.20 | $3,000 | 11,796,357 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-18 | Purchase | +30,000 | $0.19 | $5,700 | 11,826,357 | D |
| Open-market purchases · 45,000 sh · avg $0.19 · $8,700 | |||||||
Loading xslF345X03/doc4.xml…